- Home
- MREO vs NBB Comparison
MREO vs NBB Comparison
Compare MREO & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NBB
- Stock Information
- Founded
- MREO 2015
- NBB 2009
- Country
- MREO United Kingdom
- NBB United States
- Employees
- MREO N/A
- NBB N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- MREO Health Care
- NBB Finance
- Exchange
- MREO Nasdaq
- NBB Nasdaq
- Market Cap
- MREO 424.5M
- NBB 462.1M
- IPO Year
- MREO N/A
- NBB N/A
- Fundamental
- Price
- MREO $2.85
- NBB $15.30
- Analyst Decision
- MREO Strong Buy
- NBB
- Analyst Count
- MREO 7
- NBB 0
- Target Price
- MREO $7.71
- NBB N/A
- AVG Volume (30 Days)
- MREO 1.2M
- NBB 73.9K
- Earning Date
- MREO 08-12-2025
- NBB 01-01-0001
- Dividend Yield
- MREO N/A
- NBB 8.64%
- EPS Growth
- MREO N/A
- NBB N/A
- EPS
- MREO N/A
- NBB N/A
- Revenue
- MREO N/A
- NBB N/A
- Revenue This Year
- MREO N/A
- NBB N/A
- Revenue Next Year
- MREO $54.07
- NBB N/A
- P/E Ratio
- MREO N/A
- NBB N/A
- Revenue Growth
- MREO N/A
- NBB N/A
- 52 Week Low
- MREO $1.58
- NBB $13.67
- 52 Week High
- MREO $5.02
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- MREO 64.74
- NBB 42.06
- Support Level
- MREO $2.61
- NBB $15.48
- Resistance Level
- MREO $2.85
- NBB $15.59
- Average True Range (ATR)
- MREO 0.17
- NBB 0.16
- MACD
- MREO 0.03
- NBB -0.02
- Stochastic Oscillator
- MREO 88.83
- NBB 1.77
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.